Can LLMs Hack Enterprise Networks? Autonomous Assumed Breach Penetration-Testing Active Directory Networks—RCR Report
ACM Transactions on Software Engineering and Methodology · 30.11.2026 · 35 (11) · 1-15
DOI: 10.1145/3800584 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACM Transactions on Software Engineering and Methodology, online erschienen am 03.11.2026. Verfasst von Andreas Happe und 1 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union’s Horizon research and innovation programme.
Abstract (Originalsprache)
This is the Replicated Computational Results (RCR) Report for the article “ Can LLMs Hack Enterprise Networks ?” The article empirically investigates the efficacy and effectiveness of different LLMs for penetration-testing enterprise networks, i.e., Microsoft Active Directory Assumed-Breach Simulations. This RCR report describes the artifacts used in the article, how to create an evaluation setup, and highlights the analysis scripts provided within our prototype.
Förderung
- European Union’s Horizon research and innovation programme
Zitieren
APA
Happe, A., & Cito, J. (2026). Can LLMs Hack Enterprise Networks? Autonomous Assumed Breach Penetration-Testing Active Directory Networks—RCR Report. ACM Transactions on Software Engineering and Methodology, 35(11), 1-15. https://doi.org/10.1145/3800584
Vancouver
Happe A, Cito J. Can LLMs Hack Enterprise Networks? Autonomous Assumed Breach Penetration-Testing Active Directory Networks—RCR Report. ACM Transactions on Software Engineering and Methodology. 2026;35(11):1-15. doi:10.1145/3800584
BibTeX
@article{Happe2026,
author = {Happe, Andreas and Cito, Jürgen},
title = {Can LLMs Hack Enterprise Networks? Autonomous Assumed Breach Penetration-Testing Active Directory Networks—RCR Report},
journal = {ACM Transactions on Software Engineering and Methodology},
year = {2026},
volume = {35},
number = {11},
pages = {1--15},
doi = {10.1145/3800584}
}
EUVIMED